Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001573072-26-000002
Filing Date
2026-02-10
Accepted
2026-02-10 16:15:06
Documents
1
Period of Report
2026-02-10

Document Format Files

Seq Description Document Type Size
1 form4-02102026_040201.html 4  
1 form4-02102026_040201.xml 4 31848
  Complete submission text file 0001573072-26-000002.txt   33251
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 39 YORKSHIRE DR OAKLAND CA 94618
Business Address
Novack David F (Reporting) CIK: 0001573072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 26616150